{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:37:29Z","timestamp":1782311849697,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460377"],"award-info":[{"award-number":["81460377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270479"],"award-info":[{"award-number":["81270479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470832"],"award-info":[{"award-number":["81470832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670507"],"award-info":[{"award-number":["81670507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Project from MOST of China","award":["2015BAI13B07"],"award-info":[{"award-number":["2015BAI13B07"]}]},{"name":"the Jiangxi Province Talent 555 Project"},{"name":"the National Science and Technology Major Projects program for \u201cMajor New Drugs Innovation and Development\u201d of China","award":["2011ZX09302-007-03"],"award-info":[{"award-number":["2011ZX09302-007-03"]}]},{"name":"the Natural Science Foundation of Jiangxi Province, China","award":["20151BAB205041"],"award-info":[{"award-number":["20151BAB205041"]}]},{"name":"the Graduate Student Innovation Foundation of Jiangxi Province, China","award":["YC2015-B021"],"award-info":[{"award-number":["YC2015-B021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13046-018-0795-2","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T05:20:09Z","timestamp":1534915209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["PTEN lipid phosphatase inactivation links the hippo and PI3K\/Akt pathways to induce gastric tumorigenesis"],"prefix":"10.1186","volume":"37","author":[{"given":"Wenting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianshuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"issue":"2","key":"795_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"795_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"795_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","volume":"61","author":"N Deng","year":"2012","unstructured":"Deng N, Goh LK, Wang H, Das K, Tao J, Tan IB, et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut. 2012;61(5):673\u201384.","journal-title":"Gut"},{"issue":"5308","key":"795_CR4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275(5308):1943\u20137.","journal-title":"Science"},{"issue":"5","key":"795_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cellsig.2014.01.025","volume":"26","author":"LL Zhang","year":"2014","unstructured":"Zhang LL, Liu J, Lei S, Zhang J, Zhou W, Yu HG. PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell Signal. 2014;26(5):1011\u201320.","journal-title":"Cell Signal"},{"issue":"4","key":"795_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tibs.2014.02.006","volume":"39","author":"BD Hopkins","year":"2014","unstructured":"Hopkins BD, Hodakoski C, Barrows D, Mense SM, Parsons RE. PTEN function: the long and the short of it. Trends Biochem Sci. 2014;39(4):183\u201390.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"795_CR7","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/nm.3328","volume":"19","author":"MG Filbin","year":"2013","unstructured":"Filbin MG, Dabral SK, Pazyra-Murphy MF, Ramkissoon S, Kung AL, Pak E, et al. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Nat Med. 2013;19(11):1518\u201323.","journal-title":"Nat Med"},{"issue":"3","key":"795_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2014.03.027","volume":"157","author":"A Papa","year":"2014","unstructured":"Papa A, Wan L, Bonora M, Salmena L, Song MS, Hobbs RM, et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell. 2014;157(3):595\u2013610.","journal-title":"Cell"},{"issue":"22","key":"795_CR9","first-page":"5002","volume":"58","author":"FB Furnari","year":"1998","unstructured":"Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 1998;58(22):5002\u20138.","journal-title":"Cancer Res"},{"issue":"5","key":"795_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1101\/gad.9.5.534","volume":"9","author":"RW Justice","year":"1995","unstructured":"Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9(5):534\u201346.","journal-title":"Genes Dev"},{"issue":"12","key":"795_CR11","first-page":"15933","volume":"8","author":"MH Kim","year":"2015","unstructured":"Kim MH, Kim YK, Shin DH, Lee HJ, Shin N, Kim A, et al. Yes associated protein is a poor prognostic factor in well-differentiated lung adenocarcinoma. Int J Clin Exp Pathol. 2015;8(12):15933\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"795_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1746-1596-9-125","volume":"9","author":"L Sun","year":"2014","unstructured":"Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J. Prognostic impact of TAZ and beta-catenin expression in adenocarcinoma of the esophagogastric junction. Diagn Pathol. 2014;9:125.","journal-title":"Diagn Pathol"},{"issue":"34","key":"795_CR13","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1038\/onc.2015.505","volume":"35","author":"H Yagi","year":"2016","unstructured":"Yagi H, Asanoma K, Ohgami T, Ichinoe A, Sonoda K, Kato K. GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer. Oncogene. 2016;35(34):4471\u201380.","journal-title":"Oncogene"},{"key":"795_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1471-2407-13-349","volume":"13","author":"JY Liu","year":"2013","unstructured":"Liu JY, Li YH, Lin HX, Liao YJ, Mai SJ, Liu ZW, et al. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder. BMC Cancer. 2013;13:349.","journal-title":"BMC Cancer"},{"issue":"6","key":"795_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000370252","volume":"31","author":"H Li","year":"2014","unstructured":"Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang T, et al. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Dig Surg. 2014;31(6):468\u201378.","journal-title":"Dig Surg"},{"issue":"4","key":"795_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and Cancer. Cell. 2015;163(4):811\u201328.","journal-title":"Cell"},{"issue":"37","key":"795_CR17","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. The hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci U S A. 2012;109(37):E2441\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"795_CR18","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.1093\/emboj\/19.24.6778","volume":"19","author":"F Kanai","year":"2000","unstructured":"Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000;19(24):6778\u201391.","journal-title":"EMBO J"},{"key":"795_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/bse0530111","volume":"53","author":"C Cherrett","year":"2012","unstructured":"Cherrett C, Furutani-Seiki M, Bagby S. The hippo pathway: key interaction and catalytic domains in organ growth control, stem cell self-renewal and tissue regeneration. Essays Biochem. 2012;53:111\u201327.","journal-title":"Essays Biochem"},{"issue":"31","key":"795_CR20","doi-asserted-by":"publisher","first-page":"31916","DOI":"10.18632\/oncotarget.5577","volume":"6","author":"Z Yang","year":"2015","unstructured":"Yang Z, Xie C, Xu W, Liu G, Cao X, Li W, et al. Phosphorylation and inactivation of PTEN at residues Ser380\/Thr382\/383 induced by helicobacter pylori promotes gastric epithelial cell survival through PI3K\/Akt pathway. Oncotarget. 2015;6(31):31916\u201326.","journal-title":"Oncotarget"},{"issue":"23","key":"795_CR21","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1073\/pnas.95.23.13513","volume":"95","author":"MP Myers","year":"1998","unstructured":"Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A. 1998;95(23):13513\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"795_CR22","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1073\/pnas.0912524107","volume":"107","author":"H Wang","year":"2010","unstructured":"Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen HZ, et al. Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A. 2010;107(11):5142\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"795_CR23","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ncb2615","volume":"14","author":"K Tumaneng","year":"2012","unstructured":"Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, et al. YAP mediates crosstalk between the hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol. 2012;14(12):1322\u20139.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"795_CR24","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1158\/2159-8290.CD-15-0330","volume":"5","author":"ME Garcia-Rendueles","year":"2015","unstructured":"Garcia-Rendueles ME, Ricarte-Filho JC, Untch BR, Landa I, Knauf JA, Voza F, et al. NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition. Cancer Discov. 2015;5(11):1178\u201393.","journal-title":"Cancer Discov"},{"issue":"1","key":"795_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clinre.2012.03.002","volume":"37","author":"Z Yang","year":"2013","unstructured":"Yang Z, Yuan XG, Chen J, Luo SW, Luo ZJ, Lu NH. Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: a novel mechanism of PTEN inactivation. Clin Res Hepatol Gastroenterol. 2013;37(1):72\u20139.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"795_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012;13(5):283\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"41","key":"795_CR27","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"TL Yuan","year":"2008","unstructured":"Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008;27(41):5497\u2013510.","journal-title":"Oncogene"},{"issue":"11","key":"795_CR28","first-page":"2124","volume":"57","author":"DM Li","year":"1997","unstructured":"Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 1997;57(11):2124\u20139.","journal-title":"Cancer Res"},{"issue":"4","key":"795_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15(4):356\u201362.","journal-title":"Nat Genet"},{"issue":"4","key":"795_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrc3037","volume":"11","author":"MC Hollander","year":"2011","unstructured":"Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer. 2011;11(4):289\u2013301.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"795_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/sj.onc.1207059","volume":"23","author":"NT Nassif","year":"2004","unstructured":"Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C, et al. PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene. 2004;23(2):617\u201328.","journal-title":"Oncogene"},{"issue":"21","key":"795_CR32","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1093\/hmg\/ddr337","volume":"20","author":"I Rodriguez-Escudero","year":"2011","unstructured":"Rodriguez-Escudero I, Oliver MD, Andres-Pons A, Molina M, Cid VJ, Pulido R. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Hum Mol Genet. 2011;20(21):4132\u201342.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"795_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/labinvest.3780422","volume":"82","author":"YH Kang","year":"2002","unstructured":"Kang YH, Lee HS, Kim WH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Investig. 2002;82(3):285\u201391.","journal-title":"Lab Investig"},{"issue":"8","key":"795_CR34","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/molbev\/msr065","volume":"28","author":"D Hilman","year":"2011","unstructured":"Hilman D, Gat U. The evolutionary history of YAP and the hippo\/YAP pathway. Mol Biol Evol. 2011;28(8):2403\u201317.","journal-title":"Mol Biol Evol"},{"issue":"4","key":"795_CR35","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150(4):780\u201391.","journal-title":"Cell"},{"issue":"7430","key":"795_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11693","volume":"493","author":"ER Barry","year":"2013","unstructured":"Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493(7430):106\u201310.","journal-title":"Nature"},{"issue":"4","key":"795_CR37","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s13277-013-0751-x","volume":"34","author":"Y Wang","year":"2013","unstructured":"Wang Y, Xie C, Li Q, Xu K, Wang E. Clinical and prognostic significance of yes-associated protein in colorectal cancer. Tumour Biol. 2013;34(4):2169\u201374.","journal-title":"Tumour Biol"},{"issue":"3","key":"795_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10549-011-1435-0","volume":"131","author":"R Tufail","year":"2012","unstructured":"Tufail R, Jorda M, Zhao W, Reis I, Nawaz Z. Loss of yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas. Breast Cancer Res Treat. 2012;131(3):743\u201350.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"795_CR39","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s13277-015-3297-2","volume":"36","author":"YC Liu","year":"2015","unstructured":"Liu YC, Wang YZ. Role of yes-associated protein 1 in gliomas: pathologic and therapeutic aspects. Tumour Biol. 2015;36(4):2223\u20137.","journal-title":"Tumour Biol"},{"issue":"4","key":"795_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/IGC.0b013e31828c8619","volume":"23","author":"T Liu","year":"2013","unstructured":"Liu T, Liu Y, Gao H, Meng F, Yang S, Lou G. Clinical significance of yes-associated protein overexpression in cervical carcinoma: the differential effects based on histotypes. Int J Gynecol Cancer. 2013;23(4):735\u201342.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"795_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cub.2008.02.006","volume":"18","author":"M Praskova","year":"2008","unstructured":"Praskova M, Xia F, Avruch J. MOBKL1A\/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol. 2008;18(5):311\u201321.","journal-title":"Curr Biol"},{"issue":"11","key":"795_CR42","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/emboj.2013.102","volume":"32","author":"M Kim","year":"2013","unstructured":"Kim M, Kim M, Lee S, Kuninaka S, Saya H, Lee H, et al. cAMP\/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J. 2013;32(11):1543\u201355.","journal-title":"EMBO J"},{"issue":"1","key":"795_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ydbio.2012.06.014","volume":"369","author":"X Ye","year":"2012","unstructured":"Ye X, Deng Y, Lai ZC. Akt is negatively regulated by hippo signaling for growth inhibition in Drosophila. Dev Biol. 2012;369(1):115\u201323.","journal-title":"Dev Biol"},{"issue":"15","key":"795_CR44","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1038\/onc.2011.379","volume":"31","author":"LA Fernandez","year":"2012","unstructured":"Fernandez LA, Squatrito M, Northcott P, Awan A, Holland EC, Taylor MD, et al. Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation. Oncogene. 2012;31(15):1923\u201337.","journal-title":"Oncogene"},{"issue":"6","key":"795_CR45","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1074\/jbc.M112.436311","volume":"288","author":"DP Del Re","year":"2013","unstructured":"Del Re DP, Yang Y, Nakano N, Cho J, Zhai P, Yamamoto T, et al. Yes-associated protein isoform 1 (yap 1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem. 2013;288(6):3977\u201388.","journal-title":"J Biol Chem"},{"issue":"1","key":"795_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCRESAHA.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, et al. Pi3kcb links hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116(1):35\u201345.","journal-title":"Circ Res"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-018-0795-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:41:07Z","timestamp":1569008467000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-018-0795-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/s13046-018-0795-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733858735.793580839","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"3 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal studies complied with the Fourth Military Medical University animal use guidelines, and the protocol was approved by the Medical Research Ethics Committee and the Institutional Review Board of the First Affiliated Hospital of Nanchang University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"198"}}